Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

por Gordon, Jessica K., Martyanov, Viktor, Magro, Cynthia, Wildman, Horatio F., Wood, Tammara A., Huang, Wei-Ti, Crow, Mary K., Whitfield, Michael L., Spiera, Robert F.
Publicado 2015

Real-World Efficacy and Tolerability of Brigatinib in Patients with Non-Small Cell Lung Cancer with Prior ALK-TKIs in the United States

por Jahanzeb, Mohammad, Lin, Huamao M, Wu, Yanyu, Zhang, Pingkuan, Gorritz, Magdaliz, McGuiness, Catherine B, Huang, Wei-Ti, Sun, Kainan, Chen, Chi-Chang, Camidge, D Ross
Publicado 2022